New microbial
air sampler minimizes false positives and eliminates costly sterilization steps
The BioCapt®
Single-Use Microbial Impactor, designed by and offered exclusively through
Particle Measuring Systems, helps minimize false positives for microbial
activity in pharmaceutical cleanrooms by reducing contamination from handling
of microbial plates. This results in a decrease in the number investigations
and time associated with those investigations, allowing personnel to focus on
improving production operations. Additionally, many costly and time consuming
sterilization steps, such as autoclaving, disinfecting, handling and logistics
are eliminated.
The impactor design creates a new solution by integrating an
agar media plate and sampling head into a single unit, replacing the media plate
and stainless steel sampling head while minimizing media exposure. Direct
operator contact with the media plate is prevented, which reduces the risk of
improper handling and removes the need for traditional air sampler
sterilization steps. Reliable results and no more false positives from excessive
handling mean significant financial savings and elimination of time spent on
investigating false positive results.
This new device has a proven recovery of microorganisms
under stressed conditions after two hours of continuous air sampling (25 L/min
flow rate) reducing the number of plate changes required for continuous air
sampling.
“This innovative
approach to microbial air sampling and monitoring builds on the collection
efficiencies of our BioCapt stainless steel impactor, while also virtually
eliminating false positives through specialized packaging and single-use
application,” said Giovanni Scialo, Vice President of Life Sciences for
Particle Measuring Systems.
The BioCapt Single-Use Microbial Impactor is ready to use,
simple to implement, and is packaged with three samplers in a multi-bagged,
gamma-irradiated, VHP impermeable package.